Analyst Note: Goldman Cautious On Abbott, Lilly
Goldman Sachs analyst takes more cautious views on Abbott Laboratories, Eli Lilly
10:09AM 12/01/09
'Fast Money' Recap: Sorting Out Dubai
The trading panel discussed the impact of the Dubai debt crisis on the markets.
08:13PM 11/30/09
Weekly Roundup (Action Alerts PLUS $)
The flow of positive economic data adds to the year-end bullish case.
04:42PM 11/27/09
Stocks Under $10 Weekly Summary (Stocks Under $10 $)
We focused on researching new names for the model portfolio this week and used Friday's pullback to add shares to one holding.
02:17PM 11/27/09
'Fast Money' Portfolios of the Week
Here's what the 'Fast Money' crew's been talking about lately.
12:45PM 11/27/09
Establishing a Healthy New Holding (ETF Action - Alerts $)
Initiating a play on U.S.-based drugmakers, as this group is currently showing a great deal of promise.
09:16AM 11/27/09
INSIDE WASHINGTON: Stream Of WH Health Care Visits
INSIDE WASHINGTON: Lobbyists, health care heavyweights visited White House early and often
10:48AM 11/26/09
INSIDE WASHINGTON: Stream Of WH Health Care Visits
INSIDE WASHINGTON: Lobbyists, health care heavyweights visited White House early and often
01:12PM 11/25/09
'Fast Money' Recap: Gold Conundrum
The trading panel got into a spirited debate over the soaring price of gold.
08:24PM 11/24/09
Poniard Finds Cash to Keep Lights On: BioBuzz
Poniard faces a cash-crunch situation after a failed drug test last week.
12:59PM 11/23/09
Healthcare Stocks: Safe and Speculative
NEW YORK (TheStreet) -- Allos Therapeutics is the best speculative bet in the sector. Watch this video for the safest and biggest growth stock to add to your portfolio.
12:56PM 11/23/09
A Pair of Updates (Stocks Under $10 $)
Two model portfolio names are in the news today amid chatter on an obesity-drug study and a takeout rumor.
12:28PM 11/23/09
Cel-Sci Chairman Sells Stock, Despite Sweetheart Loan Deal: BioBuzz
Shareholders are on the hook for a generous loan repayment to Cel-Sci's founder.
10:14AM 11/23/09
FDA Issues New Obesity Drug Heart Warning: BioBuzz
Safety of Abbott's Meridia may heighten concerns for all weight-loss drugs
08:15AM 11/23/09



Connect with TheStreet